Clinical Trial

Safety and Performance of the OTTAVA System in Participants Undergoing Inguinal Hernia Repair

Study acronym: TEMPO
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess safety and performance of the OTTAVA System, through 30 days postoperative, in participants undergoing robotic-assisted inguinal hernia repair (IHR).
Protocol Amendment History 7 changes
critical Trial status changed: Withheld → Recruiting 2026-08-05
critical Phase changed: not specified -> not applicable 2026-08-05
critical Primary endpoint(s) modified 2026-08-05
notable Enrollment changed: None -> 30 2026-08-05
notable Sponsor changed: [Redacted] -> Auris Health, Inc. 2026-08-05
minor Trial arms changed: 0 -> 1 2026-08-05
notable Trial sites expanded: 0 -> 4 locations 2026-08-05
Trial Details
NCT Number NCT07298317
Lead Sponsor Auris Health, Inc.
Conditions Hernia, Inguinal
Enrollment 30 participants
Start Date 2026-03-11
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-04